Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Maria Tretiakova"
Filter
Filter
Article category
Publication year
Authors
Newsletters
What’s new in genitourinary pathology 2023: WHO 5th edition updates for urinary tract, prostate, testis, and penis
Bonnie Choy, Maria Tretiakova, Debra L. Zynger
J Pathol Transl Med. 2024;58(1):45-48.   Published online December 27, 2023
DOI: https://doi.org/10.4132/jptm.2023.12.11
  • 1,756 View
  • 327 Download
AbstractAbstract PDF
The 5th edition WHO Classification of Urinary and Male Genital Tumours (2022) introduced many significant changes relevant to urologic daily practice, mainly to renal tumors which was covered in the What’s New newsletter in September 2022. In this newsletter, we summarize the notable changes to bladder, prostate, testis, and penis based on the 5th edition of the WHO.
What’s new in kidney tumor pathology 2022: WHO 5th edition updates
Maria Tretiakova
J Pathol Transl Med. 2022;56(6):383-384.   Published online September 8, 2022
DOI: https://doi.org/10.4132/jptm.2022.08.16
  • 3,751 View
  • 534 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDF
The 5th edition WHO Classification of Urinary and Male Genital Tumours (2022) introduces significant changes relevant to daily practice, especially in the completely restructured renal cell tumor chapters. Herein we highlight the most important diagnostic updates of known kidney tumor types, new and molecularly defined entities and emerging/provisional entities.

Citations

Citations to this article as recorded by  
  • Convolutional neural networks for the differentiation between benign and malignant renal tumors with a multicenter international computed tomography dataset
    Michail E. Klontzas, Georgios Kalarakis, Emmanouil Koltsakis, Thomas Papathomas, Apostolos H. Karantanas, Antonios Tzortzakakis
    Insights into Imaging.2024;[Epub]     CrossRef
  • PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis
    Silviu Constantin Badoiu, Maria Greabu, Daniela Miricescu, Iulia-Ioana Stanescu-Spinu, Radu Ilinca, Daniela Gabriela Balan, Andra-Elena Balcangiu-Stroescu, Doina-Andrada Mihai, Ileana Adela Vacaroiu, Constantin Stefani, Viorel Jinga
    International Journal of Molecular Sciences.2023; 24(9): 8391.     CrossRef
  • Machine Learning Integrating 99mTc Sestamibi SPECT/CT and Radiomics Data Achieves Optimal Characterization of Renal Oncocytic Tumors
    Michail E. Klontzas, Emmanouil Koltsakis, Georgios Kalarakis, Kiril Trpkov, Thomas Papathomas, Apostolos H. Karantanas, Antonios Tzortzakakis
    Cancers.2023; 15(14): 3553.     CrossRef
  • Serum Oxidative and Nitrosative Stress Markers in Clear Cell Renal Cell Carcinoma
    Sabina Galiniak, Marek Biesiadecki, Mateusz Mołoń, Patrycja Olech, Krzysztof Balawender
    Cancers.2023; 15(15): 3995.     CrossRef
  • Redefining Renal Cell Carcinoma: A Molecular Perspective on Classification and Clinical Implications
    Arjun Athreya Raghavan, Ian W Gibson, Robert Wightman, Piotr Czaykowski, Jeffrey Graham
    European Medical Journal.2023; : 116.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine